IP Library › Granted Patent US 7,504,424
Granted Patent B2
US 7,504,424 · App. 11/333,663 · Granted Mar 17, 2009

Compounds for the treatment of inflammatory disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,504,424
App. No.
11/333,663
Granted
Mar 17, 2009
Kind
B2
Abstract

This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof.

Claims (5)

1. A compound selected from the group consisting of:

or a pharmaceutically acceptable salt, solvate, ester, or isomer thereof.

2. The compound of claim 1 , selected from the group consisting of:

or a pharmaceutically acceptable salt, solvate, ester or isomer thereof.

3. A pharmaceutical composition comprising at least one compound of claim 1 , or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, and at least one pharmaceutically acceptable carrier.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →